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MEETING ABSTRACT Open Access
A neutralizing monoclonal antibody (mAb A24)
directed against the transferrin receptor induces
apoptosis of tumor T lymphocytes from ATL
patients
Ivan C Moura1,2, Yves Lepelletier1, Bertrand Arnulf3, Ali Bazarbachi4, Renato C Monteiro2, Olivier Hermine1*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Adult T-cell leukemia/lymphoma (ATL) is an aggressive
lymphoid proliferative disease that exists under diverse
clinical forms ranging from chronic to acute. In contrast
to resting T cells, human T-cell lymphotropic virus type 1
(HTLV-1) infected cells constitutively express high levels
of surface transferrin receptor (TfR). Interestingly this
expression is higher in acute than in chronic forms. We
have characterized a new monoclonal antibody (mAb
A24) directed against the human TfR that blocks the pro-
liferation and induced apoptosis through mitochondria
depolarization of ATL cells ex vivo. We determined that
A24 binds TfR with an equilibrium constant (Kd) of 2.7
nM and competes with transferring for binding to TfR.
Interestingly A24 exhibits an higher affinity than transferin
when TfR are highly expressed. A24 inhibited [55Fe]-
transferrin uptake through TfR endocytosis via the clathrin
adaptor protein-2 complex pathway followed by transport
to lysosomal compartments. In monkey administration of
single and repeated doses of A24 did not induce significant
toxicity except a slight decreased of haemoglobin level,
increased of transferin and decreased of iron serum levels.
Interestingly in lymph nodes, apoptosis was observed in
germinal center in zone of high proliferation of B and T
cells. Therefore, A24 might be a safe and effective treat-
ment of ATLL particularly acute forms.
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